SAN DIEGO--(BUSINESS WIRE)--Accelrys, Inc. (NASDAQ:ACCL), a leading scientific enterprise R&D software and services company, today announced a new release of the Discovery Studio® life sciences modeling and simulation software. The release incorporates the first commercially available software for predicting protein-protein aggregation to advance biotherapeutics research. In addition, a major update to the software’s 3D-molecular ActiveX control enables researchers to display dynamic molecular visualizations in webpages, Microsoft Office® applications and Microsoft SharePoint® collaboration software.
